Remove development drug-delivery
article thumbnail

New UK drug delivery centre to support RNA therapeutic development

European Pharmaceutical Review

The Centre for Process Innovation (CPI) is set to establish a new UK Intracellular Drug Delivery Centre to develop new lipid nanoparticle (LNP) formulations for RNA medicine delivery, and a framework to advance next-generation nano delivery systems.

article thumbnail

New UK intracellular drug delivery centre to support RNA development

Pharmaceutical Technology

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. Another key focus area will be the creation of a framework to develop advanced nano-delivery systems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gerresheimer develops delivery device for drugs with higher viscosity

Outsourcing Pharma

CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drug delivery systems for newly developed biologics along with medical and diagnostic products.

article thumbnail

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop

pharmaphorum

SMi presents the 4 th Annual Ophthalmic Drugs Conference taking place on the 23 rd -24 th November 2020, in London. Workshop will be on ‘Ophthalmic Drug Delivery Development – Trials and Tribulations’. Understanding the pharmacological challenges for DD and development pathway including cost and timelines.

article thumbnail

Medincell, AbbVie link up in long-acting injectable development pact worth up to $1.9B

Fierce Pharma

After proving the merits of its drug delivery platform last year with the approval of Teva’s long-acting schizophrenia drug Uzedy, France’s Medincell has hooked another big-name partner. Medincell and AbbVie inked a development and licensing pact to create up to six long-acting injectables, Medincell said Wednesday.

83
article thumbnail

Innovation to drive advanced drug delivery market

European Pharmaceutical Review

A report by Towards Healthcare has forecasted that the advanced drug delivery market will value $375.86 The year 2023 was “significant” for the progress of advanced drug delivery systems, the author reflected. This method delivers the anti-nausea drug thioperamide to treat post-surgery sickness. billion by 2033.

FDA 84
article thumbnail

Delivery systems for biologics

European Pharmaceutical Review

1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs. Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5

FDA 89